Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (unaudited)

v3.22.2.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (unaudited) - USD ($)
Total
Common Stock
Additional Paid In Capital
Treasury Stock
Accumulated Deficit
Total The Joint Corp. stockholders' equity
Non-controlling interest
Balance, beginning common stock (in shares) at Dec. 31, 2020   14,174,237          
Balance, beginning at Dec. 31, 2020 $ 21,126,252 $ 14,174 $ 41,350,001 $ (143,111) $ (20,094,912) $ 21,126,152 $ 100
Balance, beginning treasury stock (in shares) at Dec. 31, 2020       17,167      
Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 246,494   246,494     246,494  
Issuance of restricted stock (in shares)   7,879          
Issuance of restricted stock 0 $ 8 (8)        
Exercise of stock options (in shares)   105,995          
Exercise of stock options 620,776 $ 106 620,670     620,776  
Purchases of treasury stock under employee stock plans (in shares)       13,619      
Purchases of treasury stock under employee stock plans (618,154)     $ (618,154)   (618,154)  
Net (loss) income 2,314,287       2,314,287 2,314,287  
Balance, ending common stock (in shares) at Mar. 31, 2021   14,288,111          
Balance, ending at Mar. 31, 2021 23,689,655 $ 14,288 42,217,157 $ (761,265) (17,780,625) 23,689,555 100
Balance, ending treasury stock (in shares) at Mar. 31, 2021       30,786      
Balance, beginning common stock (in shares) at Dec. 31, 2020   14,174,237          
Balance, beginning at Dec. 31, 2020 21,126,252 $ 14,174 41,350,001 $ (143,111) (20,094,912) 21,126,152 100
Balance, beginning treasury stock (in shares) at Dec. 31, 2020       17,167      
Stockholders' Equity [Roll Forward]              
Net (loss) income 6,935,751            
Balance, ending common stock (in shares) at Sep. 30, 2021   14,444,982          
Balance, ending at Sep. 30, 2021 29,661,410 $ 14,444 43,632,373 $ (850,839) (13,159,568) 29,636,410 25,000
Balance, ending treasury stock (in shares) at Sep. 30, 2021       31,643      
Balance, beginning common stock (in shares) at Mar. 31, 2021   14,288,111          
Balance, beginning at Mar. 31, 2021 23,689,655 $ 14,288 42,217,157 $ (761,265) (17,780,625) 23,689,555 100
Balance, beginning treasury stock (in shares) at Mar. 31, 2021       30,786      
Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 283,564   283,564     283,564  
Issuance of restricted stock (in shares)   4,218          
Issuance of restricted stock 0 $ 4 (4)        
Exercise of stock options (in shares)   113,819          
Exercise of stock options 641,787 $ 113 641,674     641,787  
Net (loss) income 2,683,962       2,683,962 2,683,962  
Balance, ending common stock (in shares) at Jun. 30, 2021   14,406,148          
Balance, ending at Jun. 30, 2021 27,298,968 $ 14,405 43,142,391 $ (761,265) (15,096,663) 27,298,868 100
Balance, ending treasury stock (in shares) at Jun. 30, 2021       30,786      
Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 296,850   296,850     296,850  
Issuance of restricted stock (in shares)   4,280          
Issuance of restricted stock 0 $ 4 (4)        
Exercise of stock options (in shares)   34,554          
Exercise of stock options 218,071 $ 35 218,036     218,071  
Purchases of treasury stock under employee stock plans (in shares)       857      
Purchases of treasury stock under employee stock plans (89,574)     $ (89,574)   (89,574)  
Change in redemption value of non-controlling interest 0   (24,900)     (24,900) 24,900
Net (loss) income 1,937,095       1,937,095 1,937,095  
Balance, ending common stock (in shares) at Sep. 30, 2021   14,444,982          
Balance, ending at Sep. 30, 2021 $ 29,661,410 $ 14,444 43,632,373 $ (850,839) (13,159,568) 29,636,410 25,000
Balance, ending treasury stock (in shares) at Sep. 30, 2021       31,643      
Balance, beginning common stock (in shares) at Dec. 31, 2021 14,419,712 14,451,355          
Balance, beginning at Dec. 31, 2021 $ 29,569,627 $ 14,450 43,900,157 $ (850,838) (13,519,141) 29,544,628 25,000
Balance, beginning treasury stock (in shares) at Dec. 31, 2021 31,643     31,643      
Stockholders' Equity [Roll Forward]              
Stock-based compensation expense $ 323,556   323,556     323,556  
Issuance of restricted stock (in shares)   36,722          
Issuance of restricted stock 0 $ 37 (37)        
Exercise of stock options (in shares)   4,972          
Exercise of stock options 49,623 $ 5 49,618     49,623  
Purchases of treasury stock under employee stock plans (in shares)       74      
Purchases of treasury stock under employee stock plans (2,598)     $ (2,598)   (2,598)  
Net (loss) income (205,797)       (205,797) (205,797)  
Balance, ending common stock (in shares) at Mar. 31, 2022   14,493,049          
Balance, ending at Mar. 31, 2022 $ 29,734,412 $ 14,492 44,273,294 $ (853,436) (13,724,938) 29,709,412 25,000
Balance, ending treasury stock (in shares) at Mar. 31, 2022       31,717      
Balance, beginning common stock (in shares) at Dec. 31, 2021 14,419,712 14,451,355          
Balance, beginning at Dec. 31, 2021 $ 29,569,627 $ 14,450 43,900,157 $ (850,838) (13,519,141) 29,544,628 25,000
Balance, beginning treasury stock (in shares) at Dec. 31, 2021 31,643     31,643      
Stockholders' Equity [Roll Forward]              
Net (loss) income $ 630,058            
Balance, ending common stock (in shares) at Sep. 30, 2022 14,529,679 14,561,545          
Balance, ending at Sep. 30, 2022 $ 31,525,473 $ 14,561 45,231,637 $ (856,642) (12,889,083) 31,500,473 25,000
Balance, ending treasury stock (in shares) at Sep. 30, 2022 31,866     31,866      
Balance, beginning common stock (in shares) at Mar. 31, 2022   14,493,049          
Balance, beginning at Mar. 31, 2022 $ 29,734,412 $ 14,492 44,273,294 $ (853,436) (13,724,938) 29,709,412 25,000
Balance, beginning treasury stock (in shares) at Mar. 31, 2022       31,717      
Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 340,191   340,191     340,191  
Issuance of restricted stock (in shares)   28,758          
Issuance of restricted stock 0 $ 29 (29)        
Exercise of stock options (in shares)   4,610          
Exercise of stock options 64,050 $ 5 64,045     64,050  
Net (loss) income 344,742       344,742 344,742  
Balance, ending common stock (in shares) at Jun. 30, 2022   14,526,417          
Balance, ending at Jun. 30, 2022 30,483,395 $ 14,526 44,677,501 $ (853,436) (13,380,196) 30,458,395 25,000
Balance, ending treasury stock (in shares) at Jun. 30, 2022       31,717      
Stockholders' Equity [Roll Forward]              
Stock-based compensation expense 305,815   305,815     305,815  
Issuance of restricted stock (in shares)   2,845          
Issuance of restricted stock 0 $ 3 (3)        
Exercise of stock options (in shares)   32,283          
Exercise of stock options 248,356 $ 32 248,324     248,356  
Purchases of treasury stock under employee stock plans (in shares)       149      
Purchases of treasury stock under employee stock plans (3,206)     $ (3,206)   (3,206)  
Net (loss) income $ 491,113       491,113 491,113  
Balance, ending common stock (in shares) at Sep. 30, 2022 14,529,679 14,561,545          
Balance, ending at Sep. 30, 2022 $ 31,525,473 $ 14,561 $ 45,231,637 $ (856,642) $ (12,889,083) $ 31,500,473 $ 25,000
Balance, ending treasury stock (in shares) at Sep. 30, 2022 31,866     31,866